In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®
Condition(s):Melanoma; Head and Neck Cancer; Sarcoma; Non-Melanoma Skin CancersLast Updated:December 17, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Melanoma; Head and Neck Cancer; Sarcoma; Non-Melanoma Skin CancersLast Updated:December 17, 2020Completed
Condition(s):Glioma, Malignant; Antigen-specific Vaccines; Individualized TreatmentLast Updated:October 12, 2022Recruiting
Condition(s):Non-Hodgkin’s Lymphoma; Metastatic Breast Cancer; Head and Neck Squamous Cell CarcinomaLast Updated:January 30, 2024Recruiting
Condition(s):HIV-1 Infection; HIV Infection; Healthy VolunteersLast Updated:May 8, 2014Completed
Condition(s):Pancreas Cancer; Pancreatic Cancer; Cancer of the PancreasLast Updated:March 26, 2024Active, not recruiting
Condition(s):Pediatric Brain TumorLast Updated:May 25, 2021Withdrawn
Condition(s):MelanomaLast Updated:February 13, 2018Completed
Condition(s):Head and Neck Squamous Cell Carcinoma; Breast Cancer; Sarcoma; Merkel Cell Carcinoma; Cutaneous T-Cell Lymphoma; Melanoma; Renal Cancer; Bladder Cancer; Prostate Cancer; Testicular Cancer; Solid TumorLast Updated:December 2, 2022Completed
Condition(s):Pancreatic Cancer Metastatic; Colorectal Cancer MetastaticLast Updated:May 9, 2023Withdrawn
Condition(s):Prostate CancerLast Updated:September 10, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.